Medicare to Pay for Biogen?s New Alzheimer?s Drug in Clinical-Trial Patients
Companies, agencies, institutions, etc
MembershipCustomer ServiceTools & FeaturesAdsMoreDow Jones Products
People
No matching tags
Groups
No matching tags
Physical locations
No matching tags
Places
No matching tags
Locations
No matching tags
Events
No matching tags
Summary
The Centers for Medicare and Medicaid Services said it will cover the cost of the drug Aduhelm, but as part of further clinical testing
As said here by Joseph Walker